Safety and Tolerability Study With Single Ascending Doses of ODM-102

NCT01839019 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ODM-102
DRUG: Placebo for ODM-102

Sponsor

Orion Corporation, Orion Pharma